Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Artificial Intelligence–Electrocardiography to Predict Incident Atrial Fibrillation
Christopoulos, Georgios , Graff‐Radford, Jonathan , Lopez, Camden , Yao, Xiaoxi , Attia, Zachi I. , Rabinstein, Alejandro A. , Petersen, Ronald C. , Knopman, David S. , Mielke, Michelle M. , Kremers, Walter K. , Vemuri, Prashanthi , Siontis, Konstantinos C. , Friedman, Paul A. , Knopman, David S. , Lopez, Camden L, Mielke, Michelle M , Vemuri, Prashanthi , Lopez, Camden L , Attia, Zachi I , Yao, Xiaoxi , Rabinstein, Alejandro A , Kremers, Walter K , Noseworthy, Peter A.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | November 13, 2020 | Volume: 13 | Issue: 12 | Pages: No page available

10.1161/circep.120.009355 | PMID 33185118 Get It

Background: An artificial intelligence (AI) algorithm applied to electrocardiography during sinus rhythm has recently been shown to detect concurrent episodic atrial fibrillation (AF). We sought to characterize the value of AI–enabled electrocardiography (AI-ECG) as a predictor of future AF and assess its performance compared with the CHARGE-AF score (Cohorts for Aging and Research in Genomic Epidemiology–AF) in a population-based sample. Methods: We calculated the probability of AF using AI-ECG, among participants in the population-based Mayo Clinic Study of Aging who had no history of AF at the time of the baseline study visit. Cox proportional hazards models were fit to assess the independent prognostic value and interaction between AI-ECG AF model output and CHARGE-AF score. C statistics were calculated for AI-ECG AF model output, CHARGE-AF score, and combined AI-ECG and CHARGE-AF score. Results: A total of 1936 participants with median age 75.8 (interquartile range, 70.4–81.8) years and median CHARGE-AF score 14.0 (IQR, 13.2–14.7) were included in the analysis. Participants with AI-ECG AF model output of >0.5 at the baseline visit had cumulative incidence of AF 21.5% at 2 years and 52.2% at 10 years. When included in the same model, both AI-ECG AF model output (hazard ratio, 1.76 per SD after logit transformation [95% CI, 1.51–2.04]) and CHARGE-AF score (hazard ratio, 1.90 per SD [95% CI, 1.58–2.28]) independently predicted future AF without significant interaction ( P =0.54). C statistics were 0.69 (95% CI, 0.66–0.72) for AI-ECG AF model output, 0.69 (95% CI, 0.66–0.71) for CHARGE-AF, and 0.72 (95% CI, 0.69–0.75) for combined AI-ECG and CHARGE-AF score. Conclusions: In the present study, both the AI-ECG AF model output and CHARGE-AF score independently predicted incident AF. The AI-ECG may offer a means to assess risk with a single test and without requiring manual or automated clinical data abstraction.
Aetiology and incidence of sudden cardiac arrest and death in young competitive athletes in the USA: a 4-year prospective study
Peterson, Danielle F. , Thomas, Leah , Maleszewski, Joseph J. , Siebert, David M., Lopez-Anderson, Martha, Suchsland, Monica Zigman , Schattenkerk, Jared , Harmon, Kimberly G. , Drezner, Jonathan A. , Maleszewski, Joseph, Harmon, Kimberly G , Drezner, Jonathan A , Zigman Suchsland, Monica , Kucera, Kristen L.

Mayo Clinic

British Journal of Sports Medicine | November 12, 2020 | Volume: 55 | Issue: 21 | Pages: 1196-1203

10.1136/bjsports-2020-102666 | PMID 33184114 Get It

Objective To investigate the aetiology and incidence of sudden cardiac arrest and death (SCA/D) in US competitive athletes. Methods Prospective surveillance was conducted from 1 July 2014 to 30 June 2018 through the National Center for Catastrophic Sports Injury Research in collaboration with national sports organisations. Autopsy reports, death certificates, and medical records were reviewed by an expert panel to determine aetiology. Athlete participation statistics from the National Federation of State High School Associations and the National Collegiate Athletic Association (NCAA) were used to calculate incidence rates per athlete-years (AY). Comparisons of incidence rates were calculated using incidence rate ratios (IRR) with 95% CIs. Results 331 cases of confirmed SCA/D (158 survivors; 173 fatalities) were identified; 15.4% in middle school, 61.6% in high school and 16.6% in college and professional athletes. Average age was 16.7 (11–29) years, and the majority were in male (83.7%), basketball (28.7%) or American football (25.4%) athletes. Common causes included hypertrophic cardiomyopathy (20.6%), idiopathic left ventricular hypertrophy (13.4%), coronary artery anomalies (12.0%) and autopsy-negative sudden unexplained death (9.6%). Coronary anomalies were more common in middle school athletes (28%), while cardiomyopathies (hypertrophic, arrhythmogenic, dilated, non-compaction or restricted) accounted for 47% of cases in college and professional athletes. Incidence was higher in male versus female athletes at the high school (1:43 932 AY (95% CI 1:38 101 to 1:50 907) vs 1:203 786 AY (95% CI 1:145 251 to 1:293 794); IRR 4.6 (95% CI 3.1 to 7.2)) and NCAA (1:34 906 AY (95% CI 1:25 385 to 1:49 173) vs 1:123 278 AY (95% CI 1:66 078 to 1:249 853); IRR 3.5 (95% CI 1.5 to 9.5)) levels. African American male NCAA Division I basketball players had the highest annual incidence rate of SCA/D (1:2087 AY (95% CI 1:1073 to 1:4 450)). Conclusions Cardiomyopathies account for nearly half of SCA/D cases in college and professional athletes, while coronary artery anomalies play a more prominent role than expected in middle school athletes. Over half of SCA cases in athletes result in sudden death, calling for improved prevention strategies.
Abstract 14500: Physical Activity in Individuals With the Long Qt Syndrome: Baseline Data From the Lifestyle and Exercise in Long Qt Study (live Lqts)
Lampert, Rachel , Day, Sharlene M. , Marino, Bradley S. , Burg, Matthew M. , Ainsworth, Barbara E. , Etheridge, Susan P. , Aziz, Peter F. , Czosek, Richard J. , Erickson, Christopher C. , Gray, Belinda , Johnsrude, Christopher L. , McClellan, Rebecca , Shah, Maully, Webster, Gregory G, Simone, Laura, Barth, Cheryl , Harmon, Kim S, Olshansky, Brian , Estes, Mark, Tomaselli, Gordon F., Saarel, Elizabeth V. , Cannom, David S. , Ackerman, Michael J. , Olshansky, Brian , Johnsrude, Christopher , Gray, Belinda , Tome, Maite , Abrams, Dominic J. , Cerrone, Marina , Kannankeril, Prince J. , Law, Ian H. , Molossi, Silvana M , Pérez, Marco , Sanatani, Shubhayan , Shah, Maully J. , Skinner, Jonathan R. , Ware, James S. , Webster, Gregory G, Li, Fangyong , Hall, Kevin D. , Link, Mark S.

Mayo Clinic

Circulation | November 12, 2020 | Volume: 142 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.142.suppl_3.14500 Get It

Introduction: The safety of vigorous exercise for individuals with appropriately-treated LQTS remains unproven, and physical activity practices in this population have not been described. Methods: LIVE-LQTS prospectively enrolled individuals age 8-60 years with overt LQTS or gene mutation carriers. Participants (or parents, for children) answered surveys describing activity patterns. Vigorous exercise was defined as > 6 METS for > 60 hours per year. Clinical and demographic data were derived from medical record review. Results: Among 1554 participants, 804 (52%) reported exercising vigorously, 473 of these competitively, 577 (37%) exercising at moderate, and 173 (11%) at low levels. Seven percent of those working describe jobs more active than walking, including 10 in protective services and 19 in sports/coaching. Over 90% are genotype positive, 57% are phenotype positive at rest and an additional 16% have exercise-induced QT prolongation. Forty four percent have had documented ventricular arrhythmias or syncope. Eighty-four percent are appropriately treated with either beta-blockers, ICD, and/or sympathectomy, although among beta-blocked patients, only 60% are on the most effective agents. Among adults, BMI was significantly lower among the vigorous exercisers. Conclusion: While the high percentage of vigorous exercisers seen in this study may not represent all patients with LQTS due to self-selection for study participation, many patients with LQTS are engaged in vigorous exercise or competitive athletics. Prospective follow up of this cohort is ongoing and will determine safety of vigorous exercise through comparison of arrhythmic outcomes in vigorous exercisers vs moderate/low level exercisers.
Abstract 12785: The American College of Cardiology's NCDR Afib Ablation Registry: A Summary of Initial Data Including Patient Characteristics, Procedural Characteristics, and Adverse Events
Akar, Joseph G. , Nichols, Sheila, Marcus, Gregory M. , Selzman, Kimberly A. , Varosy, Paul D. , Masoudi, Frederick A. , Du, Chengan, Curtis, Jeptha P. , Kowey, Peter R. , Marcus, Gregory M , Hsu, Jonathan C. , Marine, Joseph Edward , Natale, Andrea , Noseworthy, Peter A. , Freeman, James V.

Mayo Clinic

Circulation | November 12, 2020 | Volume: 142 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.142.suppl_3.12785 Get It

Introduction: The American College of Cardiology developed the National Cardiovascular Data Registry (NCDR) AFib Ablation Registry to assess prevalence, demographics, procedural management and outcomes of patients undergoing atrial fibrillation (AFib) ablation procedures. The objective of this registry’s first presentation is to summarize initial AFib Ablation Registry data regarding patient characteristics, procedural characteristics, and in-hospital adverse events and outcomes in those undergoing AFib ablation enrolled in the registry. Methods: Data were tabulated and summarized with simple proportions for categorical data, and mean ± standard deviation for continuous data. Results: A total of 31,345 patients who underwent AFib ablation were included in the registry (mean age 65.0 ± 10.4, 65.2% male, 57.6% paroxysmal AFib), with ablations performed at 120 hospitals, by 501 physicians. The mean CHA2DS2-VASc score of was 2.6 ± 1.6, and mean HAS-BLED score was 1.1 ± 0.9. Successful pulmonary vein isolation was able to be achieved in all veins in 94.5% of patients. The prevalence of any complication during procedural admission was 3.1%; the most common were hematoma (0.5%) and pericardial effusion requiring intervention (0.42%). The mean length of stay during the index admission (days) was 1.4 ± 7.6, and in-hospital death prevalence was 0.04% [FIGURE] . Conclusions: In conclusion, the NCDR AFib Ablation Registry is a large, national, multi-center, prospective cohort study to describe events outside the clinical trial or research setting, demonstrating successful pulmonary vein isolation in the majority of patients and a low prevalence of adverse events. Future studies from the registry will be able to help support and develop evidence-based guidelines for AFib ablation treatment and optimize patient outcomes.
Salvage of a Passive Recharge Burst Spinal Cord Stimulation Implant With 10 kHz Spinal Cord Stimulation for Failed Back Surgery Syndrome: A Case Report
Chang, Kitae, Hagedorn, Jonathan M.

Mayo Clinic

A&A Practice | November 11, 2020 | Volume: 14 | Issue: 13 | Pages: e01345

10.1213/xaa.0000000000001345 | PMID 33185406 Get It

Spinal cord stimulation (SCS) is a minimally invasive procedure used for a broad spectrum of chronic pain conditions. Unfortunately, complications can occur that may lead to device explantation. The most common reason for explantation is loss of efficacy (LoE). “Salvage therapy” is the conversion from 1 mode of stimulation to another when LoE occurs. Salvage therapy has been described with multiple modes of stimulation. To our knowledge, salvage therapy with high-frequency SCS for LoE with burst SCS has not been previously described. We present a case of salvage therapy utilizing 10 kHz SCS for LoE with a passive recharge burst SCS.
431 Prospective, randomized trial of the tumor lysate, particle only vaccine compared to the tumor lysate, particle-loaded, dendritic cell vaccine to prevent recurrence for resected stage III/IV melanoma
McCarthy, Patrick M. , Adams, Lexy, Vreeland, Timothy J. , Bohan, Phillip Kemp, Hickeron, Annelies, Campf, Jessica, Myers, John , Brown, Tommy A., Hale, Diane F. , Faries, Mark B. , Hyngstrom, John , Berger, Adam C. , Shaheen, Montaser , Wagner, Thomas E., Peoples, George E. , McCarthy, Patrick , Chick, Robert C. , Clifton, Guy T. , O’Shea, Anne E. , Bohan, Phillip M. Kemp , Jakub, James W. , Sussman, Jonathan

Mayo Clinic

Regular and young investigator award abstracts | November 9, 2020 | Volume: No volume available | Issue: No issue available | Pages: A262-A263

10.1136/jitc-2020-sitc2020.0431 Get It

Shoulder magnetic resonance imaging findings in manual wheelchair users with spinal cord injury
Jahanian, Omid , Straaten, Meegan G. Van , Goodwin, Brianna M. , Lennon, Ryan J. , Barlow, Jonathan D. , Murthy, Naveen S. , Morrow, Melissa M. , Van Straaten, Meegan G , Morrow, Melissa M , Barlow, Jonathan D , Murthy, Naveen S , Jahanian, Omid

Mayo Clinic

The Journal of Spinal Cord Medicine | November 9, 2020 | Volume: 45 | Issue: 4 | Pages: 564-574

10.1080/10790268.2020.1834774 | PMID 33166207 Get It

310 The effect of pretreatment with G-CSF prior to dendritic cell collection during the phase IIb trial of an autologous DC-based vaccine for advanced, resectable melanoma
Vreeland, Timothy J. , Adams, Lexy, McCarthy, Patrick M. , Bohan, Phillip Kemp, Hickeron, Annelies, Myers, John , Cindass, Jessica L., Brown, Tommy A., Hale, Diane F. , Faries, Mark B. , Hyngstrom, John , Berger, Adam C. , Shaheen, Montaser , Wagner, Thomas E., Peoples, George E. , McCarthy, Patrick , O’Shea, Anne E. , Chick, Robert C. , Clifton, Guy T. , Bohan, Phillip M. Kemp , Jakub, James W. , Sussman, Jonathan

Mayo Clinic

Regular and young investigator award abstracts | November 9, 2020 | Volume: No volume available | Issue: No issue available | Pages: A191.1-A191

10.1136/jitc-2020-sitc2020.0310 Get It

300 Final analysis of a prospective, randomized, double-blind, placebo-controlled phase IIb trial of tumor lysate, particle-loaded, dendritic cell vaccine in stage III/IV melanoma: 36-month analysis
Adams, Lexy, Chick, Robert C. , Vreeland, Timothy J. , McCarthy, Patrick M. , Bohan, P. Kemp, Hickeron, Annelies, Myers, John , Cindass, Jessica L., Hale, Diane F. , Faries, Mark B. , Hyngstrom, John , Berger, Adam C. , Shaheen, Montaser , Wagner, Thomas E., Peoples, George E. , McCarthy, Patrick , Clifton, Guy T. , O’Shea, Anne E. , Jakub, James W. , Sussman, Jonathan

Mayo Clinic

Regular and young investigator award abstracts | November 9, 2020 | Volume: No volume available | Issue: No issue available | Pages: A183.2-A184

10.1136/jitc-2020-sitc2020.0300 Get It

High-Sensitivity C-Reactive Protein is a Prognostic Biomarker of Six-Month Disability after Traumatic Brain Injury: Results from the TRACK-TBI Study
Xu, Linda , Yue, John K. , Korley, Frederick K. , Puccio, Ava M. , Yuh, Esther L. , Sun, Xiaoying, Rabinowitz, Miri, Vassar, Mary J. , Taylor, Sabrina R. , Winkler, Ethan A. , Puffer, Ross C. , Deng, Hansen , McCrea, Michael , Robertson, Claudia S. , Levin, Harvey S. , Dikmen, Sureyya, Okonkwo, David O. , Jain, Sonia , Manley, Geoffrey T. , Investigators, The TRACK-TBI, Boase, Kim, Bodien, Yelena, Bullock, M. Ross, Crawford, Karen, Duhaime, Ann-Christine, Ellenbogen, Richard, Feeser, V. Ramana, Ferguson, Adam R., Gaudette, Etienne, González, Luis, Gopinath, Shankar, Gullapalli, Rao, Hemphill, J. Claude, Hotz, Gillian , Kramer, Joel H. , Kreitzer, Natalie, Lindsell, Chris, Machamer, Joan , Madden, Christopher , McAllister, Thomas W. , Merchant, Randall, Noël, Florence, Palacios, Eva , Perl, Daniel, Rosand, Jonathan, Satris, Gabriella, Seabury, Seth, Toga, Arthur W. , Adeoye, Alex VaOpeolu, Bodien, Yelena, Bullock, M. Ross, Crawford, Karen, Ferguson, Adam R., Gaudette, Etienne, Gullapalli, Rao, Hemphill, J. Claude, Kreitzer, Natalie, Lindsell, Chris, Merchant, Randall, Perl, Daniel, Rosand, Jonathan, Seabury, Seth, Valadka, Alex B. , Vespa, Paul , Zafonte, Ross , Hemphill, J. Claude , Ferguson, Adam R. , Kreitzer, Natalie , Stein, Murray B. , Temkin, Nancy R. , Giacino, Joseph T. , Mukherjee, Pratik , Wang, Kevin , Markowitz, Amy J. , Diaz‐Arrastia, Ramon , Investigators, The TRACK-TBI, Adeoye, Opeolu M , Badjatia, Neeraj , Bodien, Yelena, Bullock, M. Ross, Chesnut, Randall Matthew , Corrigan, John D. , Crawford, Karen, Ferguson, Adam R., Foreman, Brandon , Gardner, Raquel C. , Gaudette, Etienne, Goldman, Dana P. , Gopinath, Shankar P. , Gullapalli, Rao, Hemphill, J. Claude, Kreitzer, Natalie, Lindsell, Chris, Martin, Alastair J. , Merchant, Randall, Nelson, Lindsay D. , Ngwenya, Laura Benjamin , Perl, Daniel, Rosand, Jonathan, Sander, Angelle M. , Schnyer, David M. , Seabury, Seth, Bodien, Yelena, Bullock, M. Ross, Crawford, Karen, Ferguson, Adam R., Gaudette, Etienne, Gullapalli, Rao, Hemphill, J. Claude, Kreitzer, Natalie, Lindsell, Chris, Merchant, Randall, Perl, Daniel, Rosand, Jonathan, Seabury, Seth

Mayo Clinic

Journal of Neurotrauma | November 9, 2020 | Volume: 38 | Issue: 7 | Pages: 918-927

10.1089/neu.2020.7177 | PMID 33161875 Get It